Nathan P. Rudemiller

Nathan P. Rudemiller

Auto-generated profile, based on publicly available information

Nathan P. Rudemiller

Division of Nephrology, Department of Medicine, Durham VA and Duke University Medical Centers, Durham, NC, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2014 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
CMCarmen De Miguel
Carmen De Miguel
NRNathan P. Rudemiller
Nathan P. Rudemiller
JAJustine M. Abais
Justine M. Abais
DMDavid L. Mattson
David L. Mattson

15 March 2013 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
PDF file
DMDavid L. Mattson
David L. Mattson
HLHayley Lund
Hayley Lund
CGChuanling Guo
Chuanling Guo
NRNathan Rudemiller
Nathan Rudemiller
AGAron M. Geurts
Aron M. Geurts
HJHoward Jacob
Howard Jacob
Hypertension and renal damage in Dahl SS rats are associated with increased infiltrating immune cells in the kidney. To examine the role of infiltrating immune cells in this disease process, a zinc finger nuclease targeting bases 672–706 of recombination-activating gene 1 (Rag1) was injected into the pronucleus of Dahl SS (SS/JrHsdMcwi) strain embryos and implanted in pseudopregnant females. This strategy yielded a rat strain with a 13-base frame-shift mutation in the target region of Rag1 and a deletion of immunoreactive Rag1 protein in the thymus. Flow cytometry demonstrated that the Rag1-null mutant rats have a significant reduction in T and B lymphocytes in the circulation and spleen. Studies were performed on SS and Rag1-null rats fed a 4.0% NaCl diet for 3 wk. The infiltration of T cells into the kidney following high-salt intake was significantly blunted in the Rag1-null rats (1.7 ± 0.6 × 105 cells/kidney) compared with the Dahl SS (5.6 ± 0.9 × 105 cells/kidney). Accompanying the reduction in infiltration of immune cells in the kidney, mean arterial blood pressure and urinary albumin excretion rate were significantly lower in Rag1-null mutants (158 ± 3 mmHg and 60 ± 16 mg/day, respectively) than in SS rats (180 ± 11 mmHg and 251 ± 37 mg/day). Finally, a histological analysis revealed that the glomerular and tubular damage in the kidneys of the SS rats fed a high-salt diet was also attenuated in the Rag1 mutants. These studies demonstrate the importance of renal infiltration of immune cells in the pathogenesis of hypertension and renal damage in Dahl SS rats.

1 March 2014 in Hypertension
Verified
Journal Article
Closed access
PDF file
NRNathan Rudemiller
Nathan Rudemiller
HLHayley Lund
Hayley Lund
HJHoward J. Jacob
Howard J. Jacob
AGAron M. Geurts
Aron M. Geurts
DMDavid L. Mattson
David L. Mattson
The CD3 ζ chain ( CD247 ), a gene involved in T-cell signaling, has been shown to associate with blood pressure in human genetic studies. To test the functional role of CD247 in hypertension and renal disease, zinc-finger nucleases targeting CD247 were injected into Dahl salt-sensitive (SS/JrHsdMcwi) embryos. The resulting 11-bp frameshift deletion in exon 1 of CD247 led to a predicted premature stop codon. Western blotting confirmed the absence of CD247 protein in the thymus, and flow cytometry (n=5–9 per group) demonstrated that the mutant rats ( CD247 –/– ) have a >99% reduction in circulating CD3 + T cells compared with littermate controls ( CD247 +/+ ). Studies were performed on age-matched, littermate male, CD247 +/+ and CD247 –/– rats fed a 4.0% NaCl diet for 3 weeks. The infiltration of CD3 + T cells into the kidney after high salt was significantly blunted in CD247 –/– (1.4±0.4×10 5 cells per kidney) when compared with that in the CD247 +/+ (8.7±2.0×10 5 cells per kidney). Accompanying the reduced infiltration of T cells, mean arterial blood pressure was significantly lower in CD247 –/– than in CD247 +/+ (134±1 versus 151±2 mm Hg). As an index of kidney disease, urinary albumin and protein excretion rates were significantly reduced in CD247 –/– (17±1 and 62±2 mg/d, respectively) when compared with that in CD247 +/+ (49±3 and 121±5 mg/d, respectively). Glomerular and renal tubular damage were also attenuated in the CD247 –/– . These studies demonstrate that functional T cells are required for the full development of Dahl salt-sensitive hypertension and indicate that the association between CD247 and hypertension in humans may be related to altered immune cell function.

1 February 2017 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
SCSteven D. Crowley
Steven D. Crowley
NRNathan P. Rudemiller
Nathan P. Rudemiller
Inappropriate activation of the renin-angiotensin system (RAS) exacerbates renal and vascular injury. Accordingly, treatment with global RAS antagonists attenuates cardiovascular risk and slows the progression of proteinuric kidney disease. By reducing BP, RAS inhibitors limit secondary immune activation responding to hemodynamic injury in the target organ. However, RAS activation in hematopoietic cells has immunologic effects that diverge from those of RAS stimulation in the kidney and vasculature. In preclinical studies, activating type 1 angiotensin (AT1) receptors in T lymphocytes and myeloid cells blunts the polarization of these cells toward proinflammatory phenotypes, protecting the kidney from hypertensive injury and fibrosis. These endogenous functions of immune AT1 receptors temper the pathogenic actions of renal and vascular AT1 receptors during hypertension. By counteracting the effects of AT1 receptor stimulation in the target organ, exogenous administration of AT2 receptor agonists or angiotensin 1–7 analogs may similarly limit inflammatory injury to the heart and kidney. Moreover, although angiotensin II is the classic effector molecule of the RAS, several RAS enzymes affect immune homeostasis independently of canonic angiotensin II generation. Thus, as reviewed here, multiple components of the RAS signaling cascade influence inflammatory cell phenotype and function with unpredictable and context-specific effects on innate and adaptive immunity.

1 February 2016 in Cell Metabolism
Verified
Journal Article
Closed access
JZJiandong Zhang
Jiandong Zhang
NRNathan P. Rudemiller
Nathan P. Rudemiller
MPMehul B. Patel
Mehul B. Patel
NKNorah S. Karlovich
Norah S. Karlovich
MWMin Wu
Min Wu
SCSteven D. Crowley
Steven D. Crowley

10 February 2018 in Annual Review of Physiology
Verified
Journal Article
Closed access
ARA. Justin Rucker
A. Justin Rucker
NRNathan P. Rudemiller
Nathan P. Rudemiller
SCSteven D. Crowley
Steven D. Crowley
The link between inappropriate salt retention in the kidney and hypertension is well recognized. However, growing evidence suggests that the immune system can play surprising roles in sodium homeostasis, such that the study of inflammatory cells and their secreted effectors has provided important insights into salt sensitivity. As part of the innate immune system, myeloid cells have diverse roles in blood pressure regulation, ranging from prohypertensive actions in the kidney, vasculature, and brain, to effects in the skin that attenuate blood pressure elevation. In parallel, T lymphocyte subsets, as key constituents of the adaptive immune compartment, have variable effects on renal sodium handling and the hypertensive response, accruing from the functions of the cytokines that they produce. Conversely, salt can directly modulate the phenotypes of myeloid and T cells, illustrating bidirectional regulatory mechanisms through which sodium and the immune system coordinately impact blood pressure. This review details the complex interplay between myeloid cells, T cells, and salt in the pathogenesis of essential hypertension.